RESOLUTION Spectra Systems, a Meylan, France-based leader in bioprocess analytical monitoring, has been sold to MilliporeSigma.  The company offers Raman spectroscopy analysis through its GMP-ready instrumentation and software. Financial details of the acquisition were not disclosed.

RESOLUTION Spectra Systems specializes in bioprocessing monitoring sensors based on Raman technology, which:

  • Provide real-time monitoring and process control.
  • Measure broad range of bioprocessing parameters, including glucose, lactate, viable cell density and other process-related impurities.
  • Monitor all parameters simultaneously with a single probe.

The acquisition of RESOLUTION Spectra Systems enhances MilliporeSigma’s ability to provide advanced process analytical technologies across its bioprocess portfolio, another critical step toward enabling the biomanufacturing facility of the future.

MilliporeSigma is the Life Sciences business of Merck KGaA, based in Darmstadt, Germany.

EC M&A acted as exclusive financial advisor to RESOLUTION Spectra Systems on this transaction.